Robert Califf Heads FDA Again Despite Financial Ties to Pharma
Robert M. Califf, MD was confirmed by the U.S. Senate to be commissioner of the Food and Drug Administration (FDA) by a vote of 50-46 on Feb. 15, 2022. Dr. Califf’s financial ties to the pharmaceutical industry was cited by some Senators as a reason they could not support his appointment. Similar concerns were expressed […]
Air Force Cadet’s COVID Vaccine Religious Exemption Denied
Opinion | Last month, a United States Air Force Academy cadet was informed by a superior officer that upon returning from the Cadet Wing’s spring break, he would receive an ultimatum: Receive the Department of Defense (DoD) mandatory COVID vaccine or be expelled from the academy upon return. Shortly thereafter, the order became official, giving […]
Moderna CEO Was Paid $18.2 Million in 2021
As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]
Robert Malone, MD On Censorship of Physicians and Scientists Concerned About Vaccine Safety
I used to believe that the FDA, NIH, and CDC were working for the people, not big pharma. I thought that if we could just re-purpose already known, safe drugs for emerging infectious diseases, we could quickly find ways to reduce the death rate. I thought that drug and vaccine development were regulated by the […]
Pfizer CEO Received $24.3 Million in Total Compensation for 2021
Pfizer CEO Albert Bourla, who recently announced that a fourth COVID-19 vaccine dose will be necessary for everyone who has already gotten three doses, was awarded $24.3 million in personal financial compensation in 2021. In addition to his $1.69 million salary, which increased by 15 percent, Bourla took home a cash incentive of $8 million, […]
FDA Approves Fourth COVID Shot. Fifth Shot Considered.
On Mar. 29, 2022, the U.S. Food and Drug Administration (FDA) approved a second booster dose (a fourth shot) of the Pfizer/BioNTech messenger RNA (mRNA) biologic BNT162b2 (“Comirnaty”) and Moderna/NIAID mRNA-1273 (“Spikevax”) for people 50 years of age and older, as well as younger individuals who are immunocompromised. The second booster would be given no […]